Xcout Intel
Domain Therapeutics
Domain Therapeutics is a French biopharmaceutical company focused on discovering and developing drugs that target G-protein-coupled receptors (GPCRs), including applications in oncology and immuno-oncology. It serves pharmaceutical and biotechnology partners through proprietary drug-discovery programs, technology platforms, and licensing or collaboration agreements.
Subscribe to see Domain Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Domain Therapeutics at a glance
Domain Therapeutics is a biotech company headquartered in France. Xcout tracks 12 named people at Domain Therapeutics, including Sean A. MacDonald (Chief Executive Officer).
Domain Therapeutics leadership
- Sean A. MacDonaldChief Executive Officer
- Stanislas-Léonard MalmezatChief Financial Officer
- Jean-Marie CuillerotChief Medical Officer
- Stephan SchannChief Scientific Officer
- Aurélie MaisnerDirector of Human Resources
- Marjorie SidhoumVice-President Business Development & Corporate Communication
6 more named people on record for Domain Therapeutics, with roles, board committees and tenure — see the full roster →
Domain Therapeutics competitors
A few of Domain Therapeutics's closest competitors — see the full list of competitors and alternatives →
Dome Therapeutics is a preclinical biotechnology company developing a nanomedicine designed to target brain cancer stem cells that survive standard glioblastoma treatments and drive tumor recurrence. Using a proprietary nanoparticle delivery platform, the company aims to cross the blood-brain barrier to deliver therapeutic payloads directly to these treatment-resistant cells.
Mebias Discovery, Inc. is a biotechnology company headquartered in Philadelphia, Pennsylvania, focused on drug discovery targeting G-protein coupled receptors.
Oncodesign Precision Medicine is a biopharmaceutical company that develops innovative therapeutic and diagnostic solutions targeting treatment resistance, metastasis, and diseases such as oncology, inflammatory bowel disease, and Parkinson's disease. Utilizing proprietary technologies like OncoSNIPER, Nanocyclix, and PROMETHE, the company advances first-in-class and best-in-class precision medicine programs to serve patients, clinicians, and pharmaceutical partners.
Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines. Its robust pipeline includes an RXFP1 agonist, currently undergoing Phase 1a and 1b clinical trials for the treatment of heart failure with preserved ejection fraction. Additional programs encompass a GPCR antagonist addressing hereditary hemorrhagic telangiectasia, a bi-functional GPCR modulator aimed at fibrosis, and various other GPCR modulators. Tectonic Therapeutic, Inc. is situated in Watertown, Massachusetts.
Evotec is a life science company that provides drug discovery and preclinical development services, working across modalities from small molecules to biotherapeutics. Through its subsidiary Just - Evotec Biologics, the company focuses on the design, development, and manufacturing of biologics to make therapies more accessible and affordable for partners in the pharmaceutical and biotechnology industries.
Defence Therapeutics is a publicly traded Canadian biotechnology company headquartered in Montreal, Quebec. It is a precision intracellular drug-delivery company focused on unlocking the full potential of cancer biologics.
Get Domain Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Domain Therapeutics in Xcout Intel
- 12 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access